Researchers in China have developed magnetically controlled microrobots made from diatoms for the treatment of glioblastoma using photodynamic therapy. These microrobots exhibit excellent magnetic ...
Honing in on four markers for effective, patient-specific devices to combat glioblastoma.
The blood–brain barrier functions as an evolutionarily optimized vascular “filter,” permitting limited penetration of small molecules like temozolomide while effectively excluding most biologics from ...
By Christy Santhosh March 6 (Reuters) - French drugmaker Servier said on Friday it would buy U.S.-based Day One ...
A major obstacle is the blood-brain barrier, which Kunwar described as similar to “Saran Wrap” surrounding every blood vessel in the brain. This barrier evolved to protect the brain from foreign ...
AIG Hospitals in Hyderabad has launched the ZAP-X Gyroscopic Neuro-Radiosurgery Platform for treating brain tumors and ...
Phase 1 clinical trials evaluate the safety and dosage of proposed new treatments. Further research is needed to test the oncolytic virus therapy’s effectiveness and side effects. Work also continues ...
Presented updated glioblastoma (“GBM”) data demonstrating durable survival and a favorable safety profile across Phase 1 and Phase 2 programs, ...
WEST LAFAYETTE, Ind. and MIAMI — Gibson Oncology, a clinical-stage private pharmaceutical company headquartered in Miami, announced it has entered Phase 2 clinical trials with LMP744 for the treatment ...
AIG Hospitals introduces the ZAP-X Gyroscopic Neuro-Radiosurgery Platform in South India, marking a significant breakthrough in non-invasive brain tumor treatment. The technology offers precise, ...
Gibson Oncology, a clinical-stage private pharmaceutical company headquartered in Miami, announced it has entered Phase 2 clinical trials with LMP744 for the treatment of first-time recurrent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results